Pharmaceutical Executive November 12, 2024
Miranda Schmalfuhs

The latest news for pharma industry insiders.

Optimizing Clinical Trial Efficiency: The Power of Simplicity for First-in-Human Studies

How industry can increase the speed of these trials while continuing to meet patient needs.

The Takeaway From Study of Midlife MS Patients: Don’t Stop Disease-Modifying Therapy

People with multiple sclerosis (MS) often stop taking disease-modifying therapy as they transition from relapsing-remitting MS to secondary progressive MS. This study shows that people who stop stop disease-modifying therapy have higher hospitalization rates and more visits to the emergency room.

From AI to Hardware Costs: Enterprise Tech Leaders Prepare for Trump 2.0

The president-elect’s focus on tariffs and reducing regulation could affect hardware costs and AI deployments, and set off an M&A frenzy, CIOs...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Bariatric Surgeons Being Put Out of Work by GLP-1 Drugs
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Pharma At A Crossroads: Navigating Cost Pressures And Regulatory Shifts In 2025
Why Walgreens Is Reportedly Considering a Private Equity Buyer
Gene Therapy Shows Long-Term Vision Benefits in Rare Eye Disease

Share This Article